Sridhar Kosaraju - Net Worth and Insider Trading

Sridhar Kosaraju Net Worth

The estimated net worth of Sridhar Kosaraju is at least $37 Million dollars as of 2024-11-13. Sridhar Kosaraju is the President of Penumbra Inc and owns about 155,351 shares of Penumbra Inc (PEN) stock worth over $37 Million. Sridhar Kosaraju is also the Director of 10x Genomics Inc and owns about 6,458 shares of 10x Genomics Inc (TXG) stock worth over $101,391. Details can be seen in Sridhar Kosaraju's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sridhar Kosaraju has not made any transactions after 2021-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Sridhar Kosaraju

Sridhar Kosaraju Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sridhar Kosaraju owns 3 companies in total, including 10x Genomics Inc (TXG) , Penumbra Inc (PEN) , and Nevro Corp (NVRO) .

Click here to see the complete history of Sridhar Kosaraju’s form 4 insider trades.

Insider Ownership Summary of Sridhar Kosaraju

Ticker	Comapny	Transaction Date	Type of Owner
TXG	10x Genomics Inc	2021-12-30	director
PEN	Penumbra Inc	2020-04-15	CFO and Head of Strategy
NVRO	Nevro Corp	2023-03-31	director

Sridhar Kosaraju Latest Holdings Summary

Sridhar Kosaraju currently owns a total of 2 stocks. Among these stocks, Sridhar Kosaraju owns 155,351 shares of Penumbra Inc (PEN) as of April 15, 2020, with a value of $37 Million and a weighting of 99.72%. Sridhar Kosaraju also owns 6,458 shares of 10x Genomics Inc (TXG) as of December 30, 2021, with a value of $101,391 and a weighting of 0.28%.

Latest Holdings of Sridhar Kosaraju

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PEN	Penumbra Inc	2020-04-15	155,351	236.22	36,697,013
TXG	10x Genomics Inc	2021-12-30	6,458	15.70	101,391

Holding Weightings of Sridhar Kosaraju

Sridhar Kosaraju Form 4 Trading Tracker

According to the SEC Form 4 filings, Sridhar Kosaraju has made a total of 4 transactions in Penumbra Inc (PEN) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Penumbra Inc is the sale of 2,500 shares on April 15, 2020, which brought Sridhar Kosaraju around $423,200.

According to the SEC Form 4 filings, Sridhar Kosaraju has made a total of 10 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in 10x Genomics Inc is the sale of 1,500 shares on December 30, 2021, which brought Sridhar Kosaraju around $225,570.

Insider Trading History of Sridhar Kosaraju

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sridhar Kosaraju Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sridhar Kosaraju Ownership Network

Ownership Network List of Sridhar Kosaraju

No Data

Ownership Network Relation of Sridhar Kosaraju

Sridhar Kosaraju Owned Company Details

What does 10x Genomics Inc do?

Who are the key executives at 10x Genomics Inc?

Sridhar Kosaraju is the director of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .

10x Genomics Inc (TXG) Insider Trades Summary

Over the past 18 months, Sridhar Kosaraju made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 93,946 shares made by Serge Saxonov , a net sale of 41,247 shares made by Benjamin J. Hindson , and a net sale of 12,784 shares made by Justin J. Mcanear .

In summary, during the past 3 months, insiders sold 14,061 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 14,061 shares. During the past 18 months, 186,174 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,174 shares.

10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

10x Genomics Inc Insider Transactions

No Available Data

What does Penumbra Inc do?

Who are the key executives at Penumbra Inc?

Sridhar Kosaraju is the CFO and Head of Strategy of Penumbra Inc. Other key executives at Penumbra Inc include director & Chairman & CEO and President Adam Elsesser , EVP & Gen. Counsel & Secretary Johanna Roberts , and director & Chief Innovator Arani Bose .

Penumbra Inc (PEN) Insider Trades Summary

Over the past 18 months, Sridhar Kosaraju made no insider transaction in Penumbra Inc (PEN). Other recent insider transactions involving Penumbra Inc (PEN) include a net sale of 9,600 shares made by Johanna Roberts , a net sale of 138,334 shares made by Adam Elsesser , and a net sale of 2,055 shares made by Don W. Kassing .

In summary, during the past 3 months, insiders sold 62,318 shares of Penumbra Inc (PEN) in total and bought 0 shares, with a net sale of 62,318 shares. During the past 18 months, 159,989 shares of Penumbra Inc (PEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,989 shares.

Penumbra Inc (PEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Penumbra Inc Insider Transactions

No Available Data

What does Nevro Corp do?

Who are the key executives at Nevro Corp?

Sridhar Kosaraju is the director of Nevro Corp. Other key executives at Nevro Corp include Chief Commercial Officer Greg Siller , President & CEO Kevin R Thornal , and Chief Accounting Officer Richard B. Carter .

Nevro Corp (NVRO) Insider Trades Summary

Over the past 18 months, Sridhar Kosaraju made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick ,

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 7,500 shares were bought by its insiders, resulting in a net purchase of 7,500 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nevro Corp Insider Transactions

No Available Data

Sridhar Kosaraju Mailing Address

Above is the net worth, insider trading, and ownership report for Sridhar Kosaraju. You might contact Sridhar Kosaraju via mailing address: 1351 Harbor Bay Parkway, Alameda Ca 94502.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.